FDA Approves Gene Therapy for Severe Pediatric LAD-I - Poll - MDSpire

FDA Approves Gene Therapy for Severe Pediatric LAD-I

Approval expands treatment option for a rare pediatric immunodeficiency

  • By

  • Kathryn Wighton

  • March 27, 2026

  • 2 min

Share

Original Source(s)

FDA Approves Gene Therapy for Severe Pediatric LAD-I

  • by Kathryn Wighton

  • March 27, 2026

Related Content

The optimal exercise for improving inhibitory control in children and adolescents with NDDs: a systematic review and network meta-analysis

Error in Results

  • May 22, 2026

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.